Secondary analysis identifies factors influencing COVID-19 vaccine behavior in PLWHA in Tennessee.
Tennessee is ranked 47th among the 50 states in the US in COVID-19 vaccine uptake, with only 63.8% of the state's eligible population being vaccinated with at least one dose of COVID-19 vaccine. In addition, Tennessee has 20,466 people living with HIV/AIDS (PLWHA), a population that can be more susceptible to opportunistic infections than the general population. With relatively high COVID-19 infection rate, lower COVID-19 vaccine uptake rate, and increasing burden of HIV in Tennessee, it is important to study COVID-19 vaccine uptake and associated factors among people living with HIV/AIDS (PLWHA) in Tennessee. The Tennessee Department of Health HIV surveillance and COVID-19 immunization dataset is a combination of enhanced HIV/AIDS Reporting System (eHARS) database and COVID-19 immunization dashboard. A secondary data analysis was completed to determine the predictors of uptake of COVID-19 vaccine uptake and the number of vaccine doses received by PLWHA in the state using logistic regression and negative binomial regression analyses respectively. There was a significant association between age group (p < 0.0001), gender (p < 0.0001), and region (p < 0.0001) with uptake of COVID-19 vaccination. In the multivariable model, individuals less than 25 years of age and residents of West Tennessee were significantly less likely to get COVID-19 vaccination. Furthermore, those with male same-sex partners were predicted to receive 1.6 times (IRR 1.68; 95% CI = 1.56–1.81 where IRR = Incidence Rate Ratio) more doses while people who inject drug (PWID) were 23.5% less likely (IRR 0.77; 95% CI = 0.69–0.85) to take more doses of COVID-19 vaccines than heterosexuals who do not inject drugs. It is imperative to concentrate efforts and strategies to improve the COVID-19 vaccine behavior among individuals younger than 25 years and people who inject drugs correcting negative perceptions of vaccines using knowledge, attitude and practice frameworks.
No takes yet. Share an insight, caveat, or question.
Olomofe et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: